or
forgot password

    • cancer clinical trials in chicago, IL

    • Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Cancer and Leukemia Group B
    Chicago, Illinois 60606
    Adult Acute Lymphoblastic Leukemia in Remission
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    University of Illinois Cancer Center

    Trial Locations
    University of Illinois Cancer Center
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Swedish Covenant Hospital
    Hematology and Oncology Associates
    Creticos Cancer Center at Advocate Illinois Masonic Medical Center
    Mount Sinai Hospital Medical Center
    Breast Cancer
    Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
    Rush University Medical Center

    Trial Locations
    Rush University Medical Center
    University of Illinois Medical Center
    Glioblastoma Multiforme, Glioblastoma, GBM, Grade IV Astrocytoma, Glioma, Brain Cancer, Brain Tumor
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    University of Illinois Cancer Center
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Veterans Affairs Medical Center - Chicago Westside Hospital
    Hematology and Oncology Associates
    Creticos Cancer Center at Advocate Illinois Masonic Medical Center
    Resurrection Medical Center
    Esophageal Cancer, Gastric Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Rush University Medical Center

    Trial Locations
    Rush University Medical Center
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Swedish Covenant Hospital
    Mercy Hospital and Medical Center
    Creticos Cancer Center at Advocate Illinois Masonic Medical Center
    Resurrection Medical Center
    Breast Cancer
    Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome
    Veterans Affairs Medical Center - Lakeside Chicago

    Trial Locations
    Veterans Affairs Medical Center - Lakeside Chicago
    Northwestern University, Northwestern Medical Faculty Foundation
    Lymphoma
    Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
    John H. Stroger Hospital of Cook County
    Chicago, Illinois 60612
    Osteoporosis, Prostate Cancer
    Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    University of Chicago Cancer Research Center
    Chicago, Illinois 60637
    Lung Cancer
    Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Chicago, Illinois 60611
    Colorectal Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Rush University Medical Center
    University of Illinois Cancer Center
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Swedish Covenant Hospital
    Mount Sinai Hospital Medical Center
    Endometrial Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Resurrection Healthcare
    Chicago, Illinois 60631
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma
    Veterans Affairs Medical Center - Lakeside Chicago

    Trial Locations
    Veterans Affairs Medical Center - Lakeside Chicago
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Lymphoma
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Hematology and Oncology Associates

    Trial Locations
    Hematology and Oncology Associates
    Northwestern University
    University of Chicago Comprehensive Cancer Center
    University of Illinois
    Jesse Brown Veterans Affairs Medical Center
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Saint Joseph Hospital

    Trial Locations
    Saint Joseph Hospital
    Resurrection Medical Center
    Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    University of Illinois Medical Center
    Kidney Cancer
    Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    University of Illinois Cancer Center
    Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell Tumor
    Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Rush University Medical Center
    Leukemia